DISCLOSEDQuarterly
BlackRock
Abbott Laboratories · NASDAQ
152,563,476 sh · $13.84B
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$13.84B
152,563,476 sh
Two Sigma Investments
13F filer
$746.0M
8,221,115 sh
Renaissance Technologies
13F filer
$127.2M
1,238,666 sh
Bridgewater Associates
13F filer
$12.0M
117,051 sh
Soros Fund Management
13F filer
$4.1M
44,750 sh
Dodge & Cox
13F filer
$1.6M
17,324 sh
Polen Capital Management
13F filer
$1.5M
15,081 sh
Gardner Russo & Quinn
13F filer
$1.0M
11,510 sh
BlackRock
Abbott Laboratories · NASDAQ
152,563,476 sh · $13.84B
Two Sigma Investments
Abbott Laboratories · NASDAQ
8,221,115 sh · $746.0M
Soros Fund Management
Abbott Laboratories · NASDAQ
44,750 sh · $4.1M
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.0M
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $1.6M
Polen Capital Management
Abbott Laboratories · NASDAQ
15,081 sh · $1.5M
Two Sigma Investments
Abbott Laboratories · NASDAQ
6,441,328 sh · $661.3M
Renaissance Technologies
Abbott Laboratories · NASDAQ
1,238,666 sh · $127.2M
Gardner Russo & Quinn
Abbott Laboratories · NASDAQ
11,510 sh · $1.2M
Dodge & Cox
Abbott Laboratories · NASDAQ
17,324 sh · $1.8M